Mar 2, 2026 04:57AM
Feb 26, 2026 04:26PM
Feb 19, 2026 05:48PM
Jan 12, 2026 06:43AM
Dec 17, 2025 07:02AM
Dec 12, 2025 07:00AM
Nov 14, 2025 07:01AM Castle Biosciences presents melanoma test data at European congress
Nov 4, 2025 03:59PM
Nov 4, 2025 03:20AM
Nov 3, 2025 04:26PM
Nov 3, 2025 07:02AM
Nov 3, 2025 07:00AM
Oct 27, 2025 12:27AM
Aug 25, 2025 07:01AM Castle Biosciences publishes studies supporting cancer test use
Aug 4, 2025 04:23PM
Jul 23, 2025 07:01AM
Jun 17, 2025 07:06AM
Jun 16, 2025 04:31PM
May 21, 2025 12:40PM
May 9, 2025 07:01AM
May 6, 2025 08:22AM KeyBanc Reiterates Overweight Rating on Castle Biosciences (CSTL) as 'TissueCypher Gains Momentum'
May 6, 2025 06:41AM
May 5, 2025 04:45PM
May 5, 2025 04:05PM
Apr 8, 2025 07:02AM
Feb 27, 2025 04:14PM
Jan 10, 2025 02:38PM
Jan 6, 2025 07:03AM Castle Biosciences (CSTL) Announces New York State Department of Health Approval of Its TissueCypher® Barrett’s Esophagus Test
Dec 23, 2024 07:05AM
Dec 19, 2024 06:56AM
Nov 5, 2024 03:50PM
Nov 5, 2024 11:49AM
Nov 5, 2024 06:54AM
Nov 5, 2024 06:14AM
Nov 4, 2024 04:21PM Castle Biosciences Inc. (CSTL) Tops Q3 EPS by 8c, provides guidance
Oct 29, 2024 06:30AM
Oct 14, 2024 06:47AM
Aug 6, 2024 07:31AM
Aug 6, 2024 06:52AM
Aug 5, 2024 04:20PM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All